BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Jan 03, 2011
 |  BC Week In Review  |  Company News  |  Other News

Breckenridge Pharmaceuticals Inc., Synthon Pharmaceuticals Inc., Watson, Aurobindo, Dr. Reddy's, Mylan, Novartis, Ranbaxy, Takeda, Teva, Torrent, Wockhardt endo

Takeda settled patent suits filed against companies that submitted ANDAs for generic versions of diabetes drugs Actos pioglitazone, ACTOplus met pioglitazone/metformin and duetact pioglitazone/glimepiride. Takeda granted Teva rights to an authorized generic version of Actos and Mylan, Watson and Ranbaxy licenses to market generic Actos in the U.S....

Read the full 235 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >